Actinogen Total Current Liabilities vs Non Currrent Assets Other Analysis

ACW Stock   0.02  0  4.00%   
Actinogen Medical financial indicator trend analysis is way more than just evaluating Actinogen Medical prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Actinogen Medical is a good investment. Please check the relationship between Actinogen Medical Total Current Liabilities and its Non Currrent Assets Other accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Actinogen Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Total Current Liabilities vs Non Currrent Assets Other

Total Current Liabilities vs Non Currrent Assets Other Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Actinogen Medical Total Current Liabilities account and Non Currrent Assets Other. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Actinogen Medical's Total Current Liabilities and Non Currrent Assets Other is -0.16. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Non Currrent Assets Other in the same time period over historical financial statements of Actinogen Medical, assuming nothing else is changed. The correlation between historical values of Actinogen Medical's Total Current Liabilities and Non Currrent Assets Other is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of Actinogen Medical are associated (or correlated) with its Non Currrent Assets Other. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Currrent Assets Other has no effect on the direction of Total Current Liabilities i.e., Actinogen Medical's Total Current Liabilities and Non Currrent Assets Other go up and down completely randomly.

Correlation Coefficient

-0.16
Relationship DirectionNegative 
Relationship StrengthInsignificant

Total Current Liabilities

Total Current Liabilities is an item on Actinogen Medical balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Actinogen Medical are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Non Currrent Assets Other

Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.
Most indicators from Actinogen Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Actinogen Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Actinogen Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Selling General Administrative is likely to drop to about 1.3 M in 2024. Issuance Of Capital Stock is likely to drop to about 11.5 M in 2024
 2021 2022 2023 2024 (projected)
Total Revenue3.6M4.9M9.9M10.4M
Depreciation And Amortization400.7K405.6K416.8K244.7K

Actinogen Medical fundamental ratios Correlations

0.70.791.00.820.740.810.880.30.320.51-0.85-0.810.650.640.860.930.860.62-0.850.550.970.36-0.320.94-0.74
0.70.860.670.470.850.920.920.330.140.63-0.52-0.950.490.150.450.860.930.68-0.860.70.76-0.080.110.61-0.76
0.790.860.760.570.750.990.90.10.410.33-0.59-0.890.860.350.610.830.910.76-0.830.40.810.1-0.160.72-0.74
1.00.670.760.830.720.780.870.310.310.51-0.85-0.780.630.650.870.920.840.59-0.830.550.970.38-0.330.94-0.72
0.820.470.570.830.370.570.660.390.10.41-0.98-0.610.530.420.970.730.650.25-0.580.430.830.21-0.290.94-0.65
0.740.850.750.720.370.80.90.20.250.63-0.45-0.880.430.180.390.80.870.79-0.830.70.80.010.250.58-0.61
0.810.920.990.780.570.80.930.150.320.41-0.6-0.940.770.330.610.870.950.77-0.870.480.830.08-0.120.72-0.77
0.880.920.90.870.660.90.930.250.210.58-0.71-0.990.610.30.670.930.990.72-0.910.650.930.080.030.8-0.77
0.30.330.10.310.390.20.150.250.190.86-0.35-0.26-0.090.130.290.480.24-0.06-0.280.80.290.040.050.41-0.56
0.320.140.410.310.10.250.320.210.190.12-0.1-0.170.590.440.210.310.20.47-0.240.110.260.23-0.290.3-0.3
0.510.630.330.510.410.630.410.580.860.12-0.42-0.58-0.040.080.310.680.550.29-0.550.990.55-0.040.250.49-0.66
-0.85-0.52-0.59-0.85-0.98-0.45-0.6-0.71-0.35-0.1-0.420.66-0.5-0.38-0.96-0.75-0.7-0.350.6-0.45-0.88-0.160.22-0.940.64
-0.81-0.95-0.89-0.78-0.61-0.88-0.94-0.99-0.26-0.17-0.580.66-0.59-0.19-0.6-0.9-0.99-0.70.88-0.66-0.870.02-0.11-0.730.77
0.650.490.860.630.530.430.770.61-0.090.59-0.04-0.5-0.590.460.610.570.630.6-0.580.020.610.24-0.390.64-0.57
0.640.150.350.650.420.180.330.30.130.440.08-0.38-0.190.460.520.520.280.26-0.470.070.450.71-0.840.53-0.4
0.860.450.610.870.970.390.610.670.290.210.31-0.96-0.60.610.520.740.660.37-0.590.340.860.27-0.390.96-0.64
0.930.860.830.920.730.80.870.930.480.310.68-0.75-0.90.570.520.740.930.62-0.90.720.920.24-0.170.86-0.87
0.860.930.910.840.650.870.950.990.240.20.55-0.7-0.990.630.280.660.930.71-0.90.630.910.060.030.78-0.78
0.620.680.760.590.250.790.770.72-0.060.470.29-0.35-0.70.60.260.370.620.71-0.660.360.68-0.010.00.47-0.57
-0.85-0.86-0.83-0.83-0.58-0.83-0.87-0.91-0.28-0.24-0.550.60.88-0.58-0.47-0.59-0.9-0.9-0.66-0.61-0.84-0.40.15-0.720.74
0.550.70.40.550.430.70.480.650.80.110.99-0.45-0.660.020.070.340.720.630.36-0.610.6-0.060.280.52-0.68
0.970.760.810.970.830.80.830.930.290.260.55-0.88-0.870.610.450.860.920.910.68-0.840.60.19-0.130.94-0.73
0.36-0.080.10.380.210.010.080.080.040.23-0.04-0.160.020.240.710.270.240.06-0.01-0.4-0.060.19-0.640.26-0.14
-0.320.11-0.16-0.33-0.290.25-0.120.030.05-0.290.250.22-0.11-0.39-0.84-0.39-0.170.030.00.150.28-0.13-0.64-0.290.14
0.940.610.720.940.940.580.720.80.410.30.49-0.94-0.730.640.530.960.860.780.47-0.720.520.940.26-0.29-0.73
-0.74-0.76-0.74-0.72-0.65-0.61-0.77-0.77-0.56-0.3-0.660.640.77-0.57-0.4-0.64-0.87-0.78-0.570.74-0.68-0.73-0.140.14-0.73
Click cells to compare fundamentals

Actinogen Medical Account Relationship Matchups

Actinogen Medical fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets11.9M18.4M23.3M15.2M21.3M22.4M
Other Current Liab611.0K291.7K502.5K613.2K699.1K734.0K
Total Current Liabilities743.8K755.1K1.5M1.8M1.4M1.4M
Total Stockholder Equity10.9M17.5M21.7M13.4M19.7M20.7M
Cash5.0M13.4M16.4M8.5M9.5M5.2M
Net Receivables2.7M1.5M3.9M3.9M9.4M9.9M
Total Liab1.0M920.3K1.6M1.8M1.6M1.7M
Common Stock47.9M60.1M76.9M78.7M100.0M105.0M
Other Current Assets60.2K90.0K104.6K344.5K108.8K134.7K
Net Debt(4.7M)(13.2M)(16.2M)(8.4M)(9.1M)(8.7M)
Retained Earnings(44.5M)(48.4M)(57.9M)(68.7M)(81.7M)(77.6M)
Accounts Payable46.8K392.2K898.7K1.1M597.2K353.5K
Non Current Assets Total3.8M3.3M2.9M2.5M2.4M2.6M
Cash And Short Term Investments5.0M13.4M16.4M8.5M9.5M6.3M
Common Stock Shares Outstanding1.2B1.5B1.8B1.9B2.2B2.3B
Liabilities And Stockholders Equity11.9M18.4M23.3M15.2M21.3M11.2M
Other Stockholder Equity(6.8M)(1.9M)(6.3M)(7.2M)(10.5M)(10.0M)
Total Current Assets8.2M15.1M20.4M12.7M18.9M19.8M
Accumulated Other Comprehensive Income7.5M7.8M9.1M10.6M1.4M1.3M
Intangible Assets3.3M3.0M2.7M2.4M2.1M2.7M
Non Currrent Assets Other(3.7M)(3.3M)(2.9M)(2.5M)(1.0)(1.05)
Net Tangible Assets7.5M14.4M19.0M11.0M12.6M10.9M
Net Invested Capital10.9M17.5M21.7M13.4M19.7M17.3M
Cash And Equivalents3.6M7.1M12.1M7.2M8.3M7.8M
Net Working Capital7.4M14.3M18.9M10.9M17.5M13.5M
Capital Stock47.9M60.1M76.9M78.7M100.0M75.5M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Actinogen Stock Analysis

When running Actinogen Medical's price analysis, check to measure Actinogen Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Actinogen Medical is operating at the current time. Most of Actinogen Medical's value examination focuses on studying past and present price action to predict the probability of Actinogen Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Actinogen Medical's price. Additionally, you may evaluate how the addition of Actinogen Medical to your portfolios can decrease your overall portfolio volatility.